London School of Economics and Political Science, UK.
BMC Public Health. 2010 Aug 19;10:500. doi: 10.1186/1471-2458-10-500.
Recent years have seen a growing research and policy interest in prevention in many developed countries. However, the actual efforts and resources devoted to prevention appear to have lagged well behind the lip service paid to the topic.
We review the evidence on the considerable existing scope for health gains from prevention as well as for greater prevention policy efforts in Germany. We also discuss the barriers to "more and better" prevention and provide modest suggestions about how some of the obstacles could be overcome.
In Germany, there are substantial health gains to be reaped from the implementation of evidence-based, cost-effective preventive interventions and policies. Barriers to more prevention include social, historical, political, legal and economic factors. While there is sufficient evidence to scale up prevention efforts in some public health domains in Germany, in general there is a comparative shortage of research on non-clinical preventive interventions. Some of the existing barriers in Germany are at least in principle amenable to change, provided sufficient political will exists. More research on prevention by itself is no panacea, but could help facilitate more policy action. In particular, there is an economic efficiency-based case for public funding and promotion of research on non-clinical preventive interventions, in Germany and beyond, to confront the peculiar challenges that set this research apart from its clinical counterpart.
近年来,许多发达国家越来越关注预防医学的研究和政策。然而,实际投入的预防措施和资源似乎远远落后于对这一主题的口头承诺。
我们回顾了证据,证明从预防中获得可观健康收益以及在德国加大预防政策力度的空间。我们还讨论了“更多和更好”预防的障碍,并就如何克服一些障碍提出了一些适度的建议。
在德国,实施基于证据、具有成本效益的预防干预措施和政策可以带来巨大的健康收益。更多预防措施的障碍包括社会、历史、政治、法律和经济因素。虽然在德国的一些公共卫生领域有足够的证据可以扩大预防工作,但总体而言,针对非临床预防干预措施的研究相对较少。德国存在的一些现有障碍至少在原则上是可以改变的,前提是有足够的政治意愿。更多的预防研究本身并不是万能的,但可以帮助促进更多的政策行动。特别是,从经济效率的角度来看,德国乃至其他国家都有理由为非临床预防干预措施的研究提供公共资金和支持,以应对使这类研究有别于临床研究的特殊挑战。